对心力衰竭进行四重疗法,减少喷射分数:这真的很重要吗?
Jiun-Ruey Hu1, Alexandra N Schwann2, Jia Wei Tan3
1Clinical and Translational Research Accelerator, Yale School of Medicine, New Haven, CT 06520, USA. Electronic address: https://twitter.com/ruey_hu.
Cardiology clinics
|September 24, 2023
概括
针对心力衰竭与减少喷射率 (HFrEF) 的指南导向医疗疗 (GDMT) 的灵活测序至关重要. 达到HFrEF治疗所有四个支柱的部分剂量比最大限度地提高只有一些更有效.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
背景情况:
- 针对心力衰竭与减少喷射率 (HFrEF) 的指南导向医学治疗 (GDMT) 传统上遵循一个固定的启动序列.
- 这种传统方法可能无法优化治疗的有效性或患者的耐受性.
- 药物发现的顺序并不一定与患者利益的最佳顺序相关.
研究的目的:
- 审查和倡导在HFrEF中灵活测序GDMT.
- 突出基于患者特定因素的个性化治疗策略的重要性.
- 强调实现所有基础HFrEF疗法的部分剂量的好处.
主要方法:
- 对当前GDMT实践和证据的文献综述.
- 在特殊患者群体中分析GDMT测序.
- 讨论药物相互作用和耐受性培养策略.
主要成果:
- GDMT药物的有效性和耐受性不仅仅取决于它们的发现顺序.
- 灵活的GDMT测序对患有伴随性疾病的患者有益,例如白心脏病,慢性脏病和心房动.
- 开始服用某些GDMT药物可以提高对其他药物的耐受性.
- 达到GDMT所有四个支柱的次最大剂量,比最大限度地提高仅一组治疗方法的效果更好.
结论:
- 在HFrEF中应考虑灵活的GDMT测序,特别是在复杂的患者群体中.
- 个性化治疗方法优于严格的协议来优化HFrEF管理.
- 综合性GDMT的目标,即使是部分剂量,对于改善患者的治疗结果至关重要.
关键词:
贝塔阻塞剂 贝塔阻塞剂准则导向的医疗治疗指南.心力衰竭与减少的喷射分数心力衰竭.矿物甲类皮质体受体对手列宁血管氨酶阿尔多素系统抑制剂序列 序列是指一个序列.糖共运输体2抑制剂 糖共运输体2抑制剂耐受性 耐受性更多相关视频
08:42Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
3.5K
09:11Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
Published on: September 22, 2014
12.0K
相关概念视频
01:22Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
01:30Heart Failure V: Medical Management
12
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
12
01:30Heart Failure IV: Classification and Diagnostic Evaluation
19
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
19
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
454
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
454
01:29Heart Failure II: Pathophysiology
14
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
14
01:29Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14